COST vs IBRX · P/E 55, rev $275.24B vs rev $51.2M
Costco Wholesale Corp (COST) versus Immunitybio Inc (IBRX) — a side-by-side from cached financials, not a winner call.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Latest reported IBRX revenue for 2026-06-30 was $51.2M. Net income was -$230.4M. Revenue was up 15.9% from 2026-03-31 to 2026-06-30. IBRX currently screens at market cap $7.88B.
COST currently screens at market cap $430.32B and trailing P/E 54.9. IBRX currently screens at market cap $7.88B.
Not investment advice. Open the COST and IBRX stock pages for the full models.
Not investment advice.